SIRPA and neoplasm: Further, CD47, a cell transmembrane protein expressed in ESCC tumor cells, can inhibit CD8+ T-cell infiltration and anti-tumor immune responses in a DC-dependent manner, by interacting with signal regulatory protein-α (SIRPα), expressed in DCs (70).